Jacobs Levy Equity Management’s Sana Biotechnology SANA Stock Holding History

Jacobs Levy Equity Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.52M	Buy	+1,868,718	New	+$6.02M	0.02%	388
2025 Q4	–	Sell	-60,475	Closed	-$215K	–	1047
2025 Q3	$215K	Buy	+60,475	New	+$219K	﹤0.01%	909
2023 Q4	–	Sell	-188,848	Closed	-$731K	–	1069
2023 Q3	$731K	Buy	188,848 +105,017	+125%	+$564K	﹤0.01%	731
2023 Q2	$500K	Sell	83,831 -201,242	-71%	-$1.16M	﹤0.01%	822
2023 Q1	$932K	Buy	+285,073	New	+$1.14M	0.01%	714

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Jacobs Levy Equity Management's SANA Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in Sana Biotechnology (SANA) in Q2 2026: 1,868,718 shares worth $6.52M. The stake represents 0.02% of the portfolio and ranks #388 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in SANA as recently as Q3 2025.

Jacobs Levy Equity Management first reported a position in SANA in Q1 2023 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Jacobs Levy Equity Management held 1,868,718 shares of Sana Biotechnology worth $6.52M as of Q2 2026.
Sana Biotechnology was a new Jacobs Levy Equity Management position in Q2 2026.
Sana Biotechnology made up 0.02% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #388 holding.
Jacobs Levy Equity Management first reported a position in Sana Biotechnology in Q1 2023 and has held it in 5 quarters since.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.